Keywords: prolonged-release, sifrol, shows, promise, boeh, ing, first

Prolonged-release Sifrol shows promise for Boeh Ing

Article | 05 May 2009

First data showing outcomes of two double-blind studies investigating the efficacy, safety and tolerability of Boehringer Ingleheim's Mirapexin/Sifrol (pramipexole) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Mirapex

Pramipexole

Go to drug listing